Aspirin Reduces Liver Fat in Clinical Trial of the Most Common Cause of Chronic Liver Disease
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Gastroenterology
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2426
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Select Publications:
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
The Adolescent and Young Adult Cancer Program was created to optimize the care, outcomes, and experiences of adolescent and young adult patients.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
Andrew Chan, MD, MPH is co-leading the global team known as PROSPECT, which received a grant of up to $25m over five years, to study early-onset colorectal cancer from Cancer Grand Challenges after an international competition.
A new COVID-19 symptom research app is recruiting millions of Americans, including healthcare professionals, cancer patients and survivors, to beat the disease.
A new study reports a 50 to 60 percent lower risk of colorectal cancer (CRC) among women who started endoscopy screening at age 45 compared to those who had not undergone screening at all.
A new study finds that racial and ethnic minorities were more hesitant or unwilling to receive a COVID-19 vaccine compared to whites. But inequitable distribution of the COVID-19 vaccine in the U.S. also contributed to lower levels of vaccine uptake by minorities.
Learn about screening, prevention, medical management and treatment options for those with gene mutations or those at hereditary risk for pancreatic cancer.